It costs a lot to start an oil sands operation, but they produce oil for years and operating expenses are low
With few new buyers, the superjumbo's fate is up in the air
Instead of fighting for more regulations, they're pushing for market-based solutions
Vessel wants YouTube stars to focus on another platform
JPMorgan's chief helps kill a Dodd-Frank rule and does the heavy lifting for Wall Street
MetaMind customizes its deep-learning software for businesses that want to learn faster
The final installment of "Serial," a cult-favorite podcast about a murder, will begin just like every other episode—with the name of a prison telecom provider
Grey took a novel approach to integrating the young generation
Customer service is one area where small businesses can beat big-box competitors
King of Prussia, Pa.
Founders: Dr. Robert Lefkowitz and Dr. Howard Rockman
VC Investment over the last four quarters: $26.1 million
Trevena, founded in January 2008, is a drug discovery company developing pharmaceuticals that target what are known as G-protein coupled receptors. Such drugs make up more than 40% of marketed drugs today, according to Trevena. The company's drug discovery platform is based on research from Duke University Medical Center, including that of founder and National Medal of Science winner Robert Lefkowitz.
Key to startup success: "We've been able to generate the strong investor support for this idea [because] the technology and the opportunity here is very, very unique, and the possibility of unlocking new areas of biology is so significantly different from what's currently out there."